ABION Inc. (KOSDAQ: A203400)
Health Care · Biotechnology · KR
₩—
— today · — 1Y
ABION Inc. (KOSDAQ: A203400) operates in the Biotechnology industry within the Health Care sector. The company is valued at $43.09M.
trading between 2.85K and 22.55K.
Tweenvest scores ABION Inc. across four factors: quality 39/100, value 25/100, growth 0/100. Its strongest factor is quality.
A203400 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.09M
- Revenue (TTM)
- $606.80K
- P/E
- —
- EPS
- -1,721.79
- Dividend yield
- —
- Beta (5Y)
- 0.97
- 52-week high
- ₩22,550.00
- 52-week low
- ₩2,850.00
- Avg volume (3M)
- —
- Shares outstanding
- 18.02M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Clene Inc.NasdaqCM: CLNN | $44.06M | $3.10 | -19.69% |
| Serina Therapeutics, Inc.NYSEAM: SER | $43.69M | $1.72 | -14.00% |
| Biomea Fusion, Inc.NasdaqGS: BMEA | $43.50M | $0.60 | +2.58% |
| CapForce Inc.OTCPK: CFOR | $43.39M | $3.50 | -12.37% |
| Psomagen, Inc.KOSDAQ: A950200 | $42.85M | ₩2,970.00 | -0.17% |
| Annovis Bio, Inc.NYSE: ANVS | $42.32M | $0.99 | -17.90% |
| Aldeyra Therapeutics, Inc.NasdaqCM: ALDX | $42.23M | $0.70 | -23.59% |
| Dogwood Therapeutics, Inc.NasdaqCM: DWTX | $41.47M | $1.22 | -12.86% |
Figures last refreshed Oct 18, 2026.